US Patent Litigations are now available. Check here

EP2217214

RATIOPHARM
Application Number
EP08859677A
Filing Date
Dec 9, 2008
Status
Granted And Under Opposition
Jun 16, 2017
Grant Date
Jul 19, 2017
External Links
Slate, Register, Google Patents

Biblio Summary

The patent EP2217214B1 was granted on Jul 19, 2017 by Ratiopharm The patent is currently Granted And Under Opposition.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2006060808
N/A
OppositionWO2007003365
N/A
OppositionWO2007103453
N/A
OppositionUS2007275052
N/A
OppositionWO2008032338
N/A
OppositionWO2008089484
N/A
OppositionWO9508532
N/A
OppositionEP1353696
N/A
OppositionUS2007049748
N/A
OppositionWO2008089984
N/A
OppositionWO2008101723
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.